Karriereverlauf von Paul F. Howley
Ehemalige bekannte Positionen von Paul F. Howley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 | 01.01.2008 |
| BAVARIAN NORDIC A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | 01.01.2002 |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Corporate Officer/Principal | 05.04.2010 | - |
Ausbildung von Paul F. Howley
| The University of Reading | Undergraduate Degree |
Statistik
International
| Malaysia | 2 |
| Vereinigtes Königreich | 2 |
| Dänemark | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BAVARIAN NORDIC A/S | Health Technology |
| PRESCIENT THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
- Börse
- Insiders
- Paul F. Howley
- Erfahrung
